Toggle light / dark theme

Mike Wang — Johns Hopkins — Hallucinogens, NeuroImmunology And The Microbiome In Mental Healthcare

Hallucinogens, neuro-immunology and the microbiome — convergent approaches in mental healthcare — mike wang, johns hopkins university.


Mike Wang, is a neuro-psychiatric researcher and adjunct teaching faculty in neuroscience at the Johns Hopkins Krieger School of Arts and Sciences.

Mike is one of the youngest principal investigators at the Johns Hopkins School of Medicine and currently leads a clinical trial examining how hallucinogenic levels of over-the-counter dextromethorphan might serve as the world’s first rapid acting oral antidepressant. (Those interested in the clinical trial for dextromethorphan can.

Mike’s work has been featured in academic journals like the American Journal of Psychiatry, as well as popular outlets like Psychology Today and VICE.

Mike received his graduate training in immunology at the Johns Hopkins Bloomberg School of Public Health studying rare viral encephalitides and neuro-immune determinants of depressive disorders.

“SuperAger” brains defy tau tangles associated with Alzheimer’s

Although the definitive causes of Alzheimer’s diseases aren’t yet fully understood, one of the leading suspects is the accumulation of abnormal proteins in the brain that impinges on the activity of the neurons. Scientists at Northwestern University have explored this phenomenon in a group of elderly individuals with excellent memory, known as SuperAgers, and found them to be far more resistant to the troublesome buildup of some of these proteins, shedding further light on how the disease may take hold.

A lot of the research into the progression of Alzheimer’s focus on a pair of proteins called amyloid and tau. Clumps of amyloid are thought to build up and develop into plaques that impact on memory and cognitive function, while tau takes the form of tangles that interfere with the way nutrients are taken up by the neurons, eventually leading to the death of the cell.

The Northwestern University researchers carried out experiments to study the prevalence of these proteins in SuperAgers, a group of subjects over the age of 80 with the memory capacity of someone 20 to 30 years younger than them. These subjects are assessed annually as part of ongoing research at Northwestern’s Mesulam Center for Cognitive Neurology and Alzheimer’s Disease.

Johns Hopkins neuroscientist wins Barancik Prize for Innovation in MS Research

Dwight E. Bergles, Ph.D., a leading neuroscientist at Johns Hopkins University School of Medicine, is the winner of the prestigious Barancik Prize for Innovation in MS Research. Bergles has pioneered the study of immature cells in the brain that can regenerate myelin-making cells after myelin is destroyed in MS. These cells, oligodendrocyte precursor cells (OPCs), hold the key to finding ways to promote myelin repair and restore function for people living with multiple sclerosis.

Reverse Age

This is the FIRST part of the interview with Rodolfo Goya.


In this video Professor Goya talks about his role in the original experiment and the progress in his current study to reproduce the results with young blood plasma.

Professor Rodolfo Goya is Senior Scientist at The National Scientific and Technical Research Council in Argentina where he is a biochemist and researcher.

Dr. Goya has led a number of studies on cellular reprogramming and restoration of function in important organs, such as the thymus and the brain. He is also studying different aspects of cryopreservation.

He was one of the authors of the paper “Reversing age: dual species measurement of epigenetic age with a single clock” and is now working in his lab to reproduce and extend the results.

/* */